期刊
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
卷 323, 期 1, 页码 C29-C45出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpcell.00024.2022
关键词
cancer; CD138; proteoglycan; syndecan-1; therapy
This review summarizes the current knowledge on the structure and functions of Syndecan-1 (SDC1) and its role in tumor biology. The review highlights the critical role of SDC1 in promoting tumorigenesis and metastasis, and emphasizes the potential of utilizing SDC1 as a novel target for cancer therapy.
Syndecan-1 (SDC1, CD138) is one of the heparan sulfate proteoglycans and is essential for maintaining normal cell morphology, interacting with the extracellular and intracellular protein repertoire, as well as mediating signaling transduction upon environmental stimuli. The critical role of SDC1 in promoting tumorigenesis and metastasis has been increasingly recognized in various cancer types, implying a promising potential of utilizing SDC1 as a novel target for cancer therapy. This review summarizes the current knowledge on SDC1 structure and functions, including its role in tumor biology. We also discuss the highlights and limitations of current SDC1-targeted therapies as well as the obstacles in developing new therapeutic methods, offering our perspective on the future directions to target SDC1 for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据